Seres Therapeutics, Inc. Common Stock (MCRB) Real-Time 本页面每 30 秒钟刷新一次。 最新更新数据 Mar 14, 2025 09:32 AM ET*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours....
Seres Therapeutics公司计划将发行的资金用于其在研药物SER-109美国市场的商业化事宜和生产,包括扩大长期生产能力、推进其在欧盟市场的临床开发以及其他一般运营用途。 原文链接: https://www.biospace.com/article/releases/seres-therapeutics-announces-1...
Seres Therapeutics公司计划将发行的资金用于其在研药物SER-109美国市场的商业化事宜和生产,包括扩大长期生产能力、推进其在欧盟市场的临床开发以及其他一般运营用途。 原文链接: https://www.biospace.com/article/releases/seres-therapeutics-announces-100-million-registered-direct-offering-of-common-stock/ ②MRM Hea...
The Investor Relations website contains information about Seres Therapeutics's business for stockholders, potential investors, and financial analysts.
“I am thrilled to join Seres as it extends its leadership position in the emerging microbiome therapeutics area,” said DesRosier. “Seres is performing truly innovative research to develop important new therapies for patients with serious diseases, in a whole new area o...
Seres Therapeutics (MCRB) stock risk factors, discover the 63 risks reported by Seres Therapeutics and see why Finance & Corporate is the top risk category.
AstraZeneca has teamed up with Seres Therapeutics to explore whether microbiome therapeutics can increase the efficacy of cancer immunotherapies. Thedealwill see AstraZeneca pay $20 million to collaborate with Seres and test SER-401 in combination with its oncology assets. ...
Seres Therapeutics, Inc. Common Stock (MCRB) After-Hours 此数据当前不可用 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4:00 - 8:00) 交易。做市商和 ECN 严格自愿参与,因此,这些时段的流动性和价格会比较低。在这种环境下,股票价格也可能波动更快。强烈建议在此...